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ABSTRACT
A growing body of evidence suggests that genes tran-
scribed by RNA polymerase III exhibit multiple func-
tions within a chromosome. While the predominant
function of these genes is the synthesis of RNA mole-
cules, certain RNA polymerase III genes also function
as genomic landmarks. Transfer RNA genes are
known to exhibit extra-transcriptional activities such
as directing Ty element integration, pausing of repli-
cation forks, overriding nucleosome positioning
sequences, repressing neighboring genes (tRNA
position effect), and acting as a barrier to the spread
of repressive chromatin. This study was designed to
identify other tRNA loci that may act as barriers to
chromatin-mediated repression, and focused on
TRT2, a tRNAThr adjacent to the STE6 a2 operator.
We show that TRT2 acts as a barrier to repression,
protecting theupstreamCBT1 genefromthe influence
of the STE6 a2 operator in MATa cells. Interestingly,
deletion of TRT2 results in an increase in CBT1 mRNA
levels in MATa cells, indicating a potential tRNA
position effect. The transcription of TRT2 itself is
unaffected by the presence of the a2 operator,
suggesting a hierarchy that favors assembly of the
RNA polymerase III complex versus assembly of adja-
cent a2 operator-mediated repressed chromatin
structures. This proposed hierarchy could explain
how tRNA genes function as barriers to the propaga-
tion of repressive chromatin.
INTRODUCTION
RNA polymerase III is predominantly responsible for the tran-
scription of small cellular RNA molecules including tRNAs,
5S RNA, 7SL RNA and in Saccharomyces cerevisiae, the
SNR6 gene encoding the spliceosome U6 RNA. Transcription
of tRNA genes is mediated by the stepwise assembly of the
TFIIIC transcription factor complex onto the box A and
box B internal control region promoter elements, followed
by recruitment of the TATA binding protein (TBP) containing
complex TFIIIB. Once all transcription factors are in place, the
RNA polymerase III enzymatic complex is recruited to initiate
high level transcription of its target genes (1–3). These RNAs
are extremely abundant in dividing cells, as tRNAs alone can
account for as much as 15% of total RNA in log phase
S.cerevisiae (4). This number suggests that tRNA genes are
transcribed at an amazingly high rate during log phase growth
(compared to RNA polymerase II genes), averaging approxi-
mately 104 transcription cycles/tRNA gene/generation, or
roughly two cycles per second. This high rate of transcription
can be explained in part by a facilitated recycling model in
which an assembled RNA polymerase III complex is
transferred from the termination site to the initiation site,
remaining assembled on the tRNA gene through multiple
rounds of transcription (5–7).
Such a persistently organized RNA polymerase III complex
could also explain several observed ‘extra-transcriptional’
roles of tRNA genes within chromosomes. In S.cerevisiae,
actively transcribed tRNA genes have been shown to direct
Ty element integration (8–10), override nucleosome position-
ing signals (11), exert repressive position effects on neighbor-
ing RNA polymerase II promoters (12–15), act as replication
fork pause sites (16), and act as a barrier to the propagation of
heterochromatic repression, by blocking the spread of silent
chromatin at the HMR locus (17). Of particular interest is the
dichotomy that in certain cases a tRNA gene is capable of
protecting a neighboring gene from repression (at HMR),
while in other instances tRNA genes can directly repress or
exert a negative influence on transcription of an adjacent RNA
polymerase II gene, a process referred to as tRNA-mediated
gene silencing (14) or tRNA position effect (15). While these
types of effects have been observed in a limited number of
cases (both natural and engineered), the genome-wide effects
of the location of RNA polymerase III complex formation on
neighboring chromosomal loci are largely unstudied.
We have previously described the heterochromatin barrier
effect attributed to the HMR-tRNA (tRNAThr[AGU]C) on
S.cerevisiae chromosome III. This tRNAThr gene prevents
the spread of Sir protein-mediated gene silencing from the
adjacent HMR locus in both reporter constructs and along
the native chromosome (17). We asked if tRNAs adjacent
to other repressed loci in S.cerevisiae could also function as
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barriers to repression of neighboring genes. TRT2 (coding for
tRNAThr[CGU]K) is a single copy tRNAThr gene that lies just
upstream of the a2 operator sequence that regulates the MATa
cell-specific STE6 gene on S.cerevisiae chromosome XI. We
specifically selected this locus for study as another example of
a tRNA gene located adjacent to a repressed region of chro-
matin, and asked whether this tRNA gene might act as a barrier
to the spread of repression. The a2 operator binds the Mcm1p/
a2p complex, and initiates MATa cell-specific repression of
MATa specific genes such as STE6 via multiple mechanisms,
including nucleosome positioning (18,19), the recruitment of
Ssn6p, Tup1p, and their associated histone deacetylases
(20–23), and direct interaction with transcriptional machinery
(24,25). This study asked whether TRT2 served as a barrier to
a2 operator-mediated repression in MATa cells, and revealed
that the same tRNA gene both protects the adjacent CBT1 gene
from a2 operator repression in MATa cells, and exerts a
potential negative tRNA position effect on CBT1 in MATa
cells. This is the first example of a tRNA gene that displays
multiple types of extra-transcriptional functions at the same
locus.
MATERIALS AND METHODS
All yeast strains were derived from wild-type S.cerevisiae
W303 (DDY2, DDY3 and DDY4, originally JRY4012,
JRY4013 and JRY2334, obtained from Jasper Rine, University
of California at Berkeley; genotypes of all yeast strains gen-
erated in this study are listed in Table 1). Since TRT2 is an
essential single copy tRNA gene, a 0.32 kb fragment of TRT2
(SGD chromosome XI coordinates 46596–46919) was cloned
by PCR into plasmids pRS414 and pRS415 (26) to cover
deletions of the gene (plasmids pDD675 and pDD676, respec-
tively). To construct the trt2–cbt1D::URA3 reporter strains
described in Figure 1, a 2.1 kb segment of the TRT2 locus
(coordinates 46162–48248) was amplified by PCR and cloned
into pCR2.1-TOPO (Invitrogen) to make plasmid pDD689.
The resulting plasmid was cut with Spe I and Xho I to remove
TRT2 and CBT1, and was replaced with the Spe I-Xho I URA3
fragment from pDD588 (URA3 cloned into Bluescript SK+) to
create plasmid pDD694, trt2–cbt1D::URA3. The modified
locus was cut out of pDD694 and transformed into the diploid
strain DDY2, and URA+ recombinants were selected and
screened by PCR to verify proper integration. This diploid
strain was then transformed with TRT2 plasmids pDD675
or pDD676 to cover the deletion, sporulated, and URA+ hap-
loids were recovered. The cbt1D::URA3 control strains were
made by direct PCR knockout of CBT1 with URA3, using
pRS406 as template. Cells were grown on yeast minimal med-
ium (YMD + 2% dextrose) lacking uracil to test for repression
of the URA3 marker gene. Yeast Nitrogen Base was purchased
from U.S. Biologicals, and YMD + all mix contained only
those nutrients required for growth of W303 strains (adenine,
histidine, leucine, lysine, tryptophan, and uracil).
To make the modified chromosomal loci, pDD689 was
mutagenized using the Quik-change kit (Stratagene) to delete
TRT2 (oligonucleotides DDO-96/97) from box A to the box B
(chromosome XI coordinates 46747–46800). The a2 operator
from coordinates 46472–46489 was deleted in the same way
using oligonucleotides DDO-123/124. Plasmids containing
deletions of TRT2 and/or the a2 operator were transformed
into DDY889 (trt2–cbt1D::URA), selected on 5-FOA, and
proper integration verified by PCR. Resulting strains contain-
ing modified STE6–CBT1 loci were backcrossed to trt2–
cbt1D::URA3 strains to obtain sibling MATa and MATa
versions.
For northern blot analysis, RNA was prepared as described
in Iyer and Struhl (27). Northern blots contained 10 mg total
RNA per lane, and were performed using Northern Max
reagents (Ambion). CBT1 northern blots were run on 1.0%
agarose gels, and the TRT2 blot in Figure 4 was run on a 1.2%
agarose gel. Northern probes were generated from PCR
Table 1. Genotypes of all yeast strains generated in this study
S.cerevisiae W303 strains Source
DDY2 MATa/MATa ade2-1/ADE2 his3-11/his3-11 leu2-3, 112/leu2-3, 112 LYS2/lys2D trp1-1/trp1-1 ura3-1/ura3-1 J. Rine
DDY3 MATa ADE2 his3-11 leu2-3,112 lys2D trp1-1 ura3-1 J. Rine
DDY4 MATa ADE2 his3-11 leu2-3,112 lys2D trp1-1 ura3-1 J. Rine
DDY889 MATa ADE2 his3-11 leu2-3,112 LYS2 trp1-1 ura3-1 trt2-cbt1D::URA3 pTRT2:LEU2 This study
DDY890 MATa ade2-1 his3-11 leu2-3,112 LYS2 trp1-1 ura3-1 trt2-cbt1D::URA3 ppr1D::HIS3 pTRT2:LEU2 This study
DDY891 MATa ADE2 his3-11 leu2-3,112 LYS2 trp1-1 ura3-1 trt2-cbt1D::URA3 ppr1D::HIS3 pTRT2:TRP1 This study
DDY902 MATa ADE2 his3-11 leu2-3,112 lys2D trp1-1 ura3-1 trt2-cbt1D::URA3 ppr1D::HIS3 pTRT2:LEU2 This study
DDY 903 MATa ade2-1 his3-11 leu2-3,112 lys2D trp1-1 ura3-1 trt2-cbt1D::URA3 ppr1D::HIS3 pTRT2:LEU2 This study
DDY974 MATa ade2-1 his3-11 leu2-3,112 LYS2 trp1-1 ura3-1 cbt1D::URA3 ppr1D::HIS3 This study
DDY975 MATa ade2-1 his3-11 leu2-3,112 LYS2 trp1-1 ura3-1 cbt1D::URA3 ppr1D::HIS3 This study
DDY1022 MATa ADE2 his3-11 leu2-3,112 LYS2 trp1-1 ura3-1 trt2D ppr1D::HIS3 pTRT2:LEU2 This study
DDY1024 MATa ADE2 his3-11 leu2-3,112 LYS2 trp1-1 ura3-1 trt2D ppr1D::HIS3 pTRT2:LEU2 This study
DDY1026 MATa ADE2 his3-11 leu2-3,112 lys2D trp1-1 ura3-1 trt2D ppr1D::HIS3 pTRT2:LEU2 This study
DDY1028 MATa ADE2 his3-11 leu2-3,112 lys2D trp1-1 ura3-1 trt2D ppr1D::HIS3 pTRT2:LEU2 This study
DDY1261 MATa ADE2 his3-11 leu2-3,112 lys2D trp1-1 ura3-1 trt2D a2 operatorD ppr1D::HIS3 pTRT2:LEU2 This study
DDY1262 MATa ADE2 his3-11 leu2-3,112 lys2D trp1-1 ura3-1 trt2D a2 operatorD ppr1D::HIS3 pTRT2:LEU2 This study
DDY1737 MATa ADE2 his3-11 leu2-3,112 LYS2 trp1-1 ura3-1 a2 operatorD This study
DDY1739 MATa ADE2 his3-11 leu2-3,112 lys2D trp1-1 ura3-1 a2 operatorD This study
DDY1740 MATa ADE2 his3-11 leu2-3,112 LYS2 trp1-1 ura3-1 a2 operatorD This study
DDY1742 MATa ADE2 his3-11 leu2-3,112 lys2D trp1-1 ura3-1 a2 operatorD This study
DDY1805 MATa ade2-1 his3-11 leu2-3,112 LYS2 trp1-1 ura3-1 trt2D pTRT2:URA3 hos1::HIS3 hos2::TRP1 rpd3::LEU2 This study
DDY1825 MATa ADE21 his3-11 leu2-3,112 lys2D trp1-1 ura3-1 trt2D pTRT2:URA3 hos1::HIS3 hos2::TRP1 rpd3::LEU2 This study
DDY1956 MATa ADE2 his3-11 leu2-3,112 lys2D trp1-1 ura3-1 trt2D ppr1D::HIS3 pTRT2:LEU2 hda1D::KanMX This study
DDY2021 MATa ADE2 his3-11 leu2-3,112 lys2D trp1-1 ura3-1 trt2D ppr1D::HIS3 pTRT2:LEU2 hda1D::KanMX This study
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products of the first 600 bp of each gene (except for TRT2,
where the entire gene was amplified) that included a T7 RNA
polymerase promoter attached to the downstream primer.
These PCR products were used as templates to synthesize
radiolabeled riboprobes using the Ambion Strip-EZ kit. All
oligonucleotide sequences used for knockouts, PCR clonings,
probe templates, and mutagenesis reactions are available on
request.
HDA1 deletion in the trt2D strain was made by standard
PCR knockout protocols using the plasmid pUG6 as a template
(28). The hos1 hos2 rpd3 strains were made by crossing trt2D
strains with strain DY6445 (MATa ade2 can1 his3 leu2 trp1
ura3 hos1::HIS3 hos2::TRP1 rpd3::LEU2), a gift from David
Stillman (University of Utah).
Chromatin immunoprecipitation was performed as
described in Kuo and Allis (29). Antibodies used were anti-
acetyl-histone H3 and anti-acetyl-histone H4 from Upstate
(catalog No. 06–599 and 06–866). An aliquot of 5 ml of a
1 : 10 dilution of DNA recovered from the immunoprecipitates
was used to program PCR reactions (Taq polymerase pur-
chased from Promega), and the same volume of a 1 : 40
dilution was used for the input controls. PCR conditions
were 95C for 2 min (initial denaturation), 95C · 30 s,
55C · 30 s, 72C · 60 s (28 cycles).
RESULTS
TRT2 can protect an integrated URA3 marker gene
from a2 operator repression
STE6 is a MATa cell-specific gene that is repressed in MATa
cells by an upstream a2 operator sequence. Several a2 opera-
tor sequences, including this particular one, have been shown
to be orientation independent in plasmid-based lacZ reporter
gene assays (30), so we wished to determine if repression was
also bi-directional in a chromosomal context. Also, since the
TRT2 tRNAThr gene lies between this a2 operator and CBT1,
the next RNA polymerase II transcribed gene upstream of
STE6, we tested whether TRT2 acts as a barrier to repression
of CBT1.
To test the hypothesis that repression spreads bi-direction-
ally from a chromosomal a2 operator, and that the TRT2 gene
acts as a barrier to a2 operator-mediated repression, we con-
structed yeast strains that contained URA3 integrated into
chromosome XI in place of CBT1, upstream of the a2 operator
site at the STE6 locus. Two sets of strains were constructed
(Figure 1A), one that retained TRT2 between the a2 operator
and URA3, and a second that replaced both CBT1 and TRT2
with URA3. Figure 1 shows the results when these strains
were streaked on minimal media lacking uracil. MATa
Figure 1. A URA3 marker gene is repressed when inserted upstream of the STE6 a2 operator site in S.cerevisiae chromosome XI. (A) The wild-type STE6–CBT1
region of chromosome XI is depicted on top. URA3 was inserted by homologous recombination upstream of the STE6a2 operator to either delete the TRT2 tRNAThr
gene (DDY890, DDY891, DDY902, and DDY903), or to retain the intervening TRT2 gene (DDY974 and DDY 975). (B) Each strain was streaked on YMD lacking
uracil (YMD  ura) and incubated for 2 days. MATa strains lacking TRT2 showed inhibited growth on medium lacking uracil, while all strains grew equally on
minimal YMD containing uracil (YMD + all).
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trt2–cbt1D::URA3 strains (Figure 1B, DDY 902 and DDY
903, wedges A and B) are considerably compromised for
growth on YMD media lacking uracil compared to isogenic
MATa (DDY974) or MATa (DDY975) strains containing
TRT2 between the operator and URA3 (wedges C and D).
URA3 is not completely repressed in these strains, as extended
incubation eventually leads to formation of colonies. This
delay in growth suggests that repression can spread from
the a2 operator in both directions along chromosome XI
and inhibit URA3 expression.
Interestingly, MATa trt2–cbt1D::URA3 strains grow
slightly better on YMD lacking uracil than MATa strains
containing TRT2, suggesting that in the absence of a2 opera-
tor-mediated repression in MATa cells, TRT2 may exert a
repressive tRNA position effect on the URA3 reporter (com-
pare DDY975, wedge D with DDY890 and 891, wedges E and
F). These results prompted us to further investigate the effects
of deleting TRT2 on the expression of CBT1, the gene naturally
upstream of STE6 on chromosome XI, in both MATa and
MATa cells.
Deletion of TRT2 from chromosome XI in MATa cells
inhibits induction of CBT1 when cells are grown on
acetate, and inhibition is dependent on the a2 operator
Cytochrome B termination (CBT1) is a gene required for
proper maturation of cytochrome b mRNA in S.cerevisiae,
and is essential for respiratory growth on non-fermentable
carbon sources such as acetate and ethanol (31). CBT1 is
located 862 bp upstream of STE6, placing it approximately
680 bp from the a2 operator. We observed that growth of wild-
type MATa S.cerevisiae in media containing acetate as a sole
carbon source (YPAc) resulted in a 3-fold induction of CBT1
mRNA compared to cells grown in dextrose (YPD, Figure 2,
compare lanes 1 versus 2). We then asked whether CBT1
expression is affected by deletion of TRT2. Since TRT2 is
an essential single copy tRNA gene, it was first deleted in a
diploid strain, the deletion was covered with an episomal copy
of TRT2 (pDD676, pRS415:TRT2:LEU2), and the resulting
diploid strain was sporulated to obtain MATa trt2D:pTRT2:
LEU2 cells. Deletion of TRT2 from chromosome XI in MATa
cells reduced both the basal and induced levels of CBT1
expression to approximately 40% of normal levels as analyzed
by northern blot analysis (Figure 2, lanes 3 and 4, 5 and 6
compared to lanes 1 and 2). This repression was dependent on
the a2 operator, as deletion of both TRT2 and a2 operator
sequences restored the normal levels of CBT1 mRNA induc-
tion (Figure 2, lanes 7–10). This result demonstrates that
repression spreads along chromosome XI upstream of the
a2 operator in the absence of TRT2, suggesting that TRT2
functions as a barrier to a2 operator-mediated repression of
CBT1 in MATa cells.
Deletion of TRT2 from chromosome XI in MATa cells
results in an increase in expression of CBT1
When CBT1 expression from a trt2D chromosome was ana-
lyzed in MATa cells, the opposite effect was observed. Figure 3
shows the results of northern blot analysis of wild-type and
MATa trt2D strains probed for CBT1 message. Deletion of
TRT2 in MATa cells leads to increased levels of CBT1
mRNA in either YPD or YPAc media, suggesting that in its
native context in MATa cells, CBT1 may be subject to a tRNA
position effect (Figure 3, compare lane 1 to lanes 2 and 3, lane
4 to lanes 5 and 6). The increased level of transcription of
CBT1 in trt2D strains is consistent with observation of the
Figure 2. Deletion of TRT2 results in the repression of CBT1 transcription in
MATa cells. Total RNA was isolated from strains containing a wild-type STE6–
CBT1 locus (DDY4, lanes 1 and 2), a mutant locus deleted for TRT2 (DDY1026,
lanes3 and4,DDY1028, lanes5 and6), andamutant locuscontainingdeletionof
both TRT2 and thea2 operator (DDY1261, lanes 7 and 8, DDY1262, lanes 9 and
10).Oddnumbered lanescontainRNAisolated fromcellsgrownondextroseasa
carbon and energy source (YPD), and even numbered lanes from cells grown on
acetate (YPAc), which induces CBT1 transcription. CBT1 mRNA levels were
reduced approximately 3-fold in strains lacking only TRT2. Results from two
independent isolates of each mutant strain are shown.
Figure 3. Deletion of TRT2 results in an increase in expression of CBT1 in
MATa cells. Wild-type MATa S.cerevisiae (DDY3, lanes 1 and 4), and MATa
trt2D (two independent isolates, DDY1022 lanes 2 and 5, and DDY1024 lanes 3
and 6), were grown on YPD (lanes 1–3) or on YPAc (lanes 4–6) and total RNA
isolated. Northern blots were probed for CBT1 mRNA as in Figure 2.
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strains analyzed in Figure 1, as MATa trt2–cbt1D::URA3
strains grew slightly better than MATa cbt1D::URA3 strains
on YMD–uracil media.
Transcription of TRT2 is unaffected by a2
operator-mediated repression
Since TRT2 is a single copy tRNA gene, its expression level
can be assayed directly by northern blotting. We next asked if
the a2 operator affects expression of TRT2 itself. Figure 4
shows TRT2 expression levels in wild-type and a2 operator
deleted MATa and MATa strains. After normalization to the
ACT1 signal, no significant difference in the level of TRT2
RNA was seen in MATa versus MATa cells, therefore TRT2 is
apparently unaffected by the presence of an adjacent active a2
operator (Figure 4, lanes 1 and 2). To further confirm that the
TRT2 gene is refractory to a2 operator repression, the operator
site was deleted in both MATa (Figure 4, lanes 3 and 4) and
MATa (lanes 5 and 6) strains, and again no difference in TRT2
levels was seen. These results demonstrate that RNA poly-
merase III transcription of TRT2 is completely impervious to
a2 operator-mediated repression.
Altered histone acetylation does not appear to be
responsible for the spread of repression
along a trt2D chromosome
The recent literature has described multiple yeast histone
deacetylases as interacting with the Ssn6p/Tup1p complex
to repress transcription. Increased histone H4 acetylation at
the STE6 promoter is observed in class I histone deacetylase
(HDAC) hos1 hos2 rpd3 triple mutant strains (23), however,
loss of Rpd3p function affects both repression and activation
of STE6 (32). Derepression of Ssn6–Tup1 regulated genes
SUC2 and MFA2 is observed in triple hos1 hos2 rpd3 strains
(23). Other Ssn6–Tup1 regulated genes, such as ENA1 appear
to require the class II HDAC HDA1 for repression, and it has
been reported that STE6 is partially derepressed in either hda1
or rpd3 strains (21). The Ssn6–Tup1 protein complex has been
shown to physically interact with all of these HDACs in vitro
(21–23).
To assess whether HDAC recruitment by Ssn6–Tup1 at the
a2 operator is responsible for CBT1 repression in the absence
of TRT2, we performed northern blots in trt2D strains mutated
for either hda1 or hos1 hos2 rpd3. Figure 5A shows that
deletion of hda1 does not relieve repression of CBT1 in a
trt2D background. The triple deletion of the class I HDACs
results in even lower levels of CBT1, suggesting that, as for
STE6 and other genes, RPD3 function is also required for
normal activated expression (32). These results suggest that
altered histone acetylation levels are not the major determinant
in spreading of repression from the operator in the absence of
TRT2.
In order to directly assess the histone acetylation state at
CBT1 in wild-type and trt2D strains, we performed chromatin
immunoprecipitation using antibodies against acetylated his-
tone H3 or histone H4. DNA immunoprecipitated from wild-
type or trt2D strains was probed by PCR with multiple primer
Figure 5. (A) Repression of CBT1 in trt2D strains is not relieved by mutation of
histone deacetylases. Northern blot analysis of CBT1 mRNA from MATa trt2D
cells containing HDAC mutations. Lanes 1 and 2, trt2D (DDY1026 and 1028);
lanes 3 and 4, trt2D hda1D (DDY1956 and DDY2021); lanes 5 and 6, trt2D
hos1D hos2D rpd3D (DDY1805 and DDY1825). (B) Chromatin
immunoprecipitation of wild-type and trt2D strains using anti-acetylated
histone H3 and H4 antibodies. MATa strains DDY4 (wild-type) and trt2D
(DDY1026 and DDY1028) were grown and processed for chromatin
immunoprecipitation. Primers sets for PCR analysis spanned the indicated
regions (approximately 200 bp each PCR product) of the CBT1 gene. No
significant difference in the level of CBT1 chromatin was seen in
immunoprecipitates from wild-type versus trt2D strains.
Figure 4. TRT2 expression is unaffectedby the presence of an activea2 operator
site. Northern blot analysis of TRT2 mRNA from wild-type MATa and MATa
strains (DDY4 and DDY3, lanes 1 and 2), a2 operator deleted MATa strains
(DDY1737 and DDY1742, lanes 3 and 4), anda2 operator deleted MATa strains
(DDY1739 and DDY1740, lanes 5 and 6). After normalization to the ACT1
signal, TRT2 mRNA levels were identical in all strains.
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sets spanning from 170 to +500 bp from the CBT1 start
codon. The data in Figure 5B showed no significant difference
in the amount of immunoprecipitated chromatin between wild-
type and trt2D strains. These results also suggest that gross
changes in histone acetylation are not the major determinant in
repression of CBT1 in the trt2D background, and that other
mechanisms of Ssn6–Tup1 repression, either nucleosome
positioning or direct interaction with the transcriptional
machinery, are responsible (see Discussion).
DISCUSSION
a2 operator-mediated repression is bi-directional at
the STE6 locus
a2 operator sites mediate repression of transcription of MATa-
cell-specific genes in MATa cells (20), and also regulate
recombination enhancer activity in mating type switching
(33,34). Transcriptional repression is mediated by binding
of the a2/Mcm1p complex to the operator sites, which then
recruit co-repressors such as the Ssn6p/Tup1p complex. Tran-
scriptional repression by a2 operator sequences is mediated by
the further recruitment of various histone deacetylases by
Ssn6p/Tup1p (21,23), by the precise stable positioning of
nucleosomes at the promoter region of the regulated gene
(18,19,35), and possibly by direct interaction with transcrip-
tional machinery (24,25). Despite a degree of asymmetry of
natural a2 operator sites in Mcm1p/a2p regulated genes, cloned
a2 operators in either orientation are able to repress transcrip-
tion of plasmid-based reporter genes (30), suggesting that
repression can spread bi-directionally from an a2 operator.
This observation led us to analyze whether repression from the
a2 operator upstream of the STE6 gene spreads bi-direction-
ally on the native chromosome, and whether the TRT2
tRNAThr gene upstream acts as a barrier to such repression.
The results shown in Figures 1 and 2 show that the STE6 a2
operator can partially repress upstream genes specifically in
MATa cells in a URA3 modified, or native chromosome XI
lacking TRT2. The results from the northern blot analysis of
CBT1 mRNA in trt2D strains shows a 3-fold repression com-
pared to wild-type cells. This repression is clearly due to the
operator sequence, as its deletion restores both the basal and
induced levels of CBT1 transcription (Figure 2). One reason
for the relatively mild repression (as compared to the complete
repression of STE6 in MATa cells) could be due to the relative
distance between the operator and the gene. The STE6 gene
starts 182 bp from the operator, while the CBT1 gene is 650 bp
away (598 bp in the trt2D strain). This increased distance may
lead to weaker repression compared to that of STE6. The range
of repression at this locus is limited to the CBT1 promoter, as
deletion of TRT2 had no effect on expression of YKL207W, the
next gene centromere proximal to CBT1 (D. Donze, unpub-
lished data). Another possible reason for the relatively mild
repression is the asymmetric nature of the STE6 a2 operator
site, which could lead to differences in repression in each
direction. A plasmid-based lacZ reporter gene was differen-
tially repressed by opposite orientations of this operator, with
the native orientation showing 1.5-fold higher repression then
the reverse orientation (30). This asymmetry may lie in an
asymmetry of direction of Hda1p activity from the operator,
which has been proposed for the ENA1 promoter (21). Most
likely, both distance and orientation are affecting the level of
repression of CBT1 compared to STE6.
TRT2 acts as a barrier to repression
Since MATa cell-specific repression of CBT1 is observed only
when the TRT2 gene is deleted (or contains only a box B point
mutation; D. Donze, unpublished data), TRT2 is acting as a
barrier to the spread of a2 operator-mediated repression. We
have previously shown that the HMR-tRNA (tRNAThr[AGU]
CR1) acts as a barrier to the spread of silencing at the HMR
locus, as it blocks repression of a MATa1 reporter gene when
juxtaposed between the gene and the silencer, and its deletion
from the natural chromosome leads to a 60% reduction of
expression of the downstream GIT1 gene (17). When tested
alongside the HMR-tRNA in the MATa1 reporter gene assay,
TRT2 showed a partial barrier activity to Sir protein-mediated
silencing (17), while it appears to completely prevent the
spread of a2 operator repression in this study. Therefore,
different tRNA genes may vary in their ability to block repres-
sion, or may have evolved specificities for different types of
repression.
The upstream spread of repression from the a2 operator into
CBT1 does not appear to be mediated by major changes in
histone acetylation, as suggested by the data in Figure 5.
Deletion of HDACs known to be involved in Ssn6p–Tup1p-
mediated repression do not result in derepression of CBT1 in
trt2D strains, and chromatin immunoprecipitation with anti-
bodies against acetylated histone H3 or H4 show no difference
in the amount of CBT1 DNA immunoprecipitated in wild-type
versus trt2D MATa strains. However, it may be that specific
histone deacetylation events may be responsible, which would
require a detailed analysis with antibodies specific for indivi-
dual acetylated residues. Tup1p has been shown to utilize
multiple mechanisms to repress transcription including
recruitment of HDACs (21–23), inducing the stable position-
ing of nucleosomes (18,19,36), and also by direct interaction
with the transcriptional machinery (24,25,37). The results pre-
sented here suggest that the latter two mechanisms of Tup1
transcriptional inhibition are most likely at work in the repres-
sion of CBT1 observed in the absence of TRT2. Since active
tRNA genes have been demonstrated to directly override
nucleosome positioning signals (11), we suggest that the bar-
rier activity of TRT2 is at least in part due to an ability to block
the spread of phased nucleosomes emanating from the a2
operator.
In the absence of repression, deletion of TRT2 results
in elevated CBT1 mRNA levels
Transfer RNA genes in S.cerevisiae have been shown to exert
a phenomenon referred to as either tRNA-mediated gene silen-
cing or tRNA position effect. In the limited number of cases
studied so far, a tRNA gene can exert a repressive effect on
transcription from a nearby RNA polymerase II promoter, and
this repression requires a transcriptionally active tRNA gene,
or at least one competent to bind TFIIIC (13–15). The genome-
wide extent of tRNA position effects is unknown, as it has
previously only been observed at a single native chromosomal
locus, PTR3. However, bioinformatic analysis suggests that
tRNA position effects may exert a modest but general effect on
nearby RNA polymerase II promoters at many loci, and has
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been suggested that position effects may regulate expression
of genes that are derepressed when tRNA expression is down-
regulated (15). The results shown in Figure 3 demonstrate that
deletion of TRT2 increases CBT1 expression in MATa cells,
where a2 operator-mediated repression is absent. This pro-
vides a second example of a potential tRNA position effect on
a native gene, supporting the bioinformatic predictions.
It should be noted that the mechanism of tRNA position
effects has not been studied in detail on native chromosomal
genes. Active tRNA genes have been shown to be localized to
nucleoli in S.cerevisiae (38,39), and a mutation in the putative
psuedouridine synthetase gene CBF5 disrupts both nucleolar
localization of tRNA synthesis and suppresses tRNA-mediated
gene silencing of a plasmid-based reporter gene (14). These
studies have suggested that nucleolar localization may be
responsible for both tRNA barrier function and tRNA position
effects, however, other possibilities exist. One could speculate
that inactivation of a tRNA gene could allow upstream acti-
vating sequences (UASs) from neighboring genes to inappro-
priately influence transcription of tRNA proximal genes,
suggesting that a tRNA (or an engaged RNA polymerase
III complex) might function somewhat as a classic metazoan
insulator element, blocking the positive signal from the UAS.
TRT2 transcription is completely resistant to the
presence of the a2 operator
Since the box B promoter element of TRT2 lies only 240 bp
from the STE6 a2 operator, we wanted to ask if transcription
of TRT2 itself was affected by its proximity to the repressive
element. The results in Figure 4 show that TRT2 is unaffected
by the presence of an active (MATa) or inactive (MATa) a2
operator, or by deletion of the operator in MATa cells. There-
fore even in the presence of a nearby active operator site, a
fully functional RNA polymerase III complex can form on the
TRT2 gene and carry out normal levels of transcription. This
suggests a hierarchy in the assembly of the RNA polymerase
III complex onto a chromosome versus the assembly and pro-
pagation of repressive structures, and such a hierarchy may
shed some light onto one aspect of the mechanism of the
barrier activity of tRNA genes.
Working models of RNA polymerase III transcription
depict the stepwise assembly of the TFIIIC transcription factor
complex onto the box A and box B sites, followed by the
recruitment of TFIIIB proteins Brf1p, Bdp1p, and TBP.
Once assembled, this transcription factor platform is able to
recruit the RNA polymerase III enzyme complex and initiate
transcription (3), in a process that no longer requires TFIIIC.
This sequence of events was determined largely from in vitro
reconstitution experiments, but recent in vivo studies suggest a
slightly different mechanism.
Chromatin immunoprecipitation studies of human cells pro-
gressing through mitosis show that as RNA polymerase III
transcription decreases during mitosis, Bdp1p and polymerase
subunits are mostly released from chromatin, but Brf1p and
TBP remain associated with both tRNA and 5S genes (40).
Studies in yeast cells during stationary phase or nutrient lim-
ited growth, conditions where RNA polymerase III transcrip-
tion is markedly reduced, show that polymerase occupancy at
a tRNA promoter is severely reduced, while TFIIIB subunit
occupancy is only partially reduced (41,42). Interestingly,
these studies show that the association of TFIIIC appears
unchanged or even increased under conditions of reduced
tRNA transcription. These results suggest a persistent associa-
tion of at least part of the RNA polymerase III machinery with
its target loci independent the transcriptional state of the gene.
This partial association of RNA polymerase III transcription
factors is also seen at ETC loci (extra TFIIIC), which appear to
have TFIIIC constitutively bound in the absence of TFIIIB and
polymerase (43). The persistent association of RNA polymer-
ase III factors may in one sense serve as an ‘epigenetic mark’
of these loci for polymerase reassembly when changing con-
ditions require the resumption of RNA polymerase III tran-
scription. Such persistent ‘marking’ of RNA polymerase III
promoters may also relate to their barrier function, as it might
allow a preferential reassembly of the RNA polymerase III
transcription complex after replication, even if the promoter
lies adjacent to silencers or other repressive operator elements.
Another feature of RNA polymerase III that may contribute
to barrier function is a process called facilitated recycling.
Stably bound RNA polymerase III complexes are known to
direct multiple rounds of transcription in vitro (44,45), and an
individual enzyme complex appears to be able to recycle
multiple times on an individual template without the need
to reform a preinitiation complex (5–7). Although observed
in vitro, this hyper-processive and persistent occupation of the
RNA polymerase III complex is likely to occur in vivo to
account for the transcription rate required to produce the
large number of tRNA molecules per yeast cell. Such a per-
sistent occupation of tRNA genes during all phases of the cell
cycle could contribute to the barrier function of tRNA genes
by again physically, and perhaps enzymatically (46) prevent-
ing the spread of repressive chromatin. With regard to the data
in Figure 4, the level of TRT2 transcription from its single
locus is identical with or without an active a2 operator, indi-
cating that TRT2 is transcribed at normal levels by the RNA
polymerase III machinery even when adjacent to repressive
chromatin. This suggests that RNA polymerase III complex
assembly, function and persistence at TRT2 are dominant over
the encroachment of repressive chromatin structures.
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